210 related articles for article (PubMed ID: 31307777)
21. HLA class II DQA and DQB epitopes: recognition of the likely binding sites of HLA-DQ alloantibodies eluted from recombinant HLA-DQ single antigen cell lines.
El-Awar N; Nguyen A; Almeshari K; Alawami M; Alzayer F; Alharbi M; Sasaki N; Terasaki PI
Hum Immunol; 2013 Sep; 74(9):1141-52. PubMed ID: 23756161
[TBL] [Abstract][Full Text] [Related]
22. HLA-DQ Mismatches and Rejection in Kidney Transplant Recipients.
Lim WH; Chapman JR; Coates PT; Lewis JR; Russ GR; Watson N; Holdsworth R; Wong G
Clin J Am Soc Nephrol; 2016 May; 11(5):875-883. PubMed ID: 27034399
[TBL] [Abstract][Full Text] [Related]
23. Chronic Active Antibody-Mediated Rejection With Donor-Specific Anti-HLA-DP Antibodies Following Living Donor Kidney Transplantation: A Case Report.
Fukuoka K; Tokodai K; Miyagi S; Nakanishi W; Nishimura R; Fujio A; Watanabe H; Taniuchi S; Naitoh T; Ishida T; Unno M; Kamei T
Transplant Proc; 2020; 52(6):1937-1939. PubMed ID: 32586663
[TBL] [Abstract][Full Text] [Related]
24. CD45RA
Tomita Y; Ishida H; Uehara S; Takiguchi S; Sato T; Nakamura M
Int Immunopharmacol; 2021 Aug; 97():107661. PubMed ID: 33887579
[TBL] [Abstract][Full Text] [Related]
25. Failure to remove de novo donor-specific HLA antibodies is influenced by antibody properties and identifies kidney recipients with late antibody-mediated rejection destined to graft loss - a retrospective study.
Cioni M; Nocera A; Tagliamacco A; Basso S; Innocente A; Fontana I; Magnasco A; Trivelli A; Klersy C; Gurrado A; Ramondetta M; Boghen S; Catenacci L; Verrina E; Garibotto G; Ghiggeri GM; Cardillo M; Ginevri F; Comoli P
Transpl Int; 2019 Jan; 32(1):38-48. PubMed ID: 30076765
[TBL] [Abstract][Full Text] [Related]
26. DQ molecules are the principal stimulators of de novo donor-specific antibodies in nonsensitized pediatric recipients receiving a first kidney transplant.
Tagliamacco A; Cioni M; Comoli P; Ramondetta M; Brambilla C; Trivelli A; Magnasco A; Biticchi R; Fontana I; Dulbecco P; Palombo D; Klersy C; Ghiggeri GM; Ginevri F; Cardillo M; Nocera A
Transpl Int; 2014 Jul; 27(7):667-73. PubMed ID: 24629017
[TBL] [Abstract][Full Text] [Related]
27. CRISPR/Cas9-Engineered HLA-Deleted Glomerular Endothelial Cells as a Tool to Predict Pathogenic Non-HLA Antibodies in Kidney Transplant Recipients.
Lamarthée B; Burger C; Leclaire C; Lebraud E; Zablocki A; Morin L; Lebreton X; Charreau B; Snanoudj R; Charbonnier S; Blein T; Hardy M; Zuber J; Satchell S; Gallazzini M; Terzi F; Legendre C; Taupin JL; Rabant M; Tinel C; Anglicheau D
J Am Soc Nephrol; 2021 Dec; 32(12):3231-3251. PubMed ID: 35167486
[TBL] [Abstract][Full Text] [Related]
28. Preformed C1q-binding Donor-specific Anti-HLA Antibodies and Graft Function After Kidney Transplantation.
Okabe Y; Noguchi H; Miyamoto K; Kaku K; Tsuchimoto A; Masutani K; Nakamura M
Transplant Proc; 2018 Dec; 50(10):3460-3466. PubMed ID: 30577221
[TBL] [Abstract][Full Text] [Related]
29. Human leukocyte antigen matching in organ transplantation: what we know and how can we make it better (Revisiting the past, improving the future).
Tambur AR
Curr Opin Organ Transplant; 2018 Aug; 23(4):470-476. PubMed ID: 29750676
[TBL] [Abstract][Full Text] [Related]
30. A refractory case of subclinical antibody-mediated rejection due to anti-HLA-DQ antibody in a kidney transplant patient.
Fujimoto T; Nakada Y; Yamamoto I; Kobayashi A; Tanno Y; Yamada H; Miki J; Ohkido I; Tsuboi N; Yamamoto H; Yokoo T
Nephrology (Carlton); 2015 Jul; 20 Suppl 2():81-5. PubMed ID: 26031594
[TBL] [Abstract][Full Text] [Related]
31. Non-HLA antibodies against endothelial targets bridging allo- and autoimmunity.
Dragun D; Catar R; Philippe A
Kidney Int; 2016 Aug; 90(2):280-288. PubMed ID: 27188505
[TBL] [Abstract][Full Text] [Related]
32. Specific "intra-allele" and "intra-broad antigen" human leukocyte antigen alloantibodies in kidney graft transplantation.
Muro M; González-Soriano MJ; Salgado G; López R; Boix F; López M; Campillo JA; Martínez P; Botella C; Gimeno L; Minguela A; Alvarez-López MR; Llorente S
Hum Immunol; 2010 Sep; 71(9):857-60. PubMed ID: 20510320
[TBL] [Abstract][Full Text] [Related]
33. Endothelial cell antibodies associated with novel targets and increased rejection.
Jackson AM; Sigdel TK; Delville M; Hsieh SC; Dai H; Bagnasco S; Montgomery RA; Sarwal MM
J Am Soc Nephrol; 2015 May; 26(5):1161-71. PubMed ID: 25381426
[TBL] [Abstract][Full Text] [Related]
34. Missing Self-Induced Activation of NK Cells Combines with Non-Complement-Fixing Donor-Specific Antibodies to Accelerate Kidney Transplant Loss in Chronic Antibody-Mediated Rejection.
Koenig A; Mezaache S; Callemeyn J; Barba T; Mathias V; Sicard A; Charreau B; Rabeyrin M; Dijoud F; Picard C; Meas-Yedid V; Olivo-Marin JC; Morelon E; Naesens M; Dubois V; Thaunat O
J Am Soc Nephrol; 2021 Feb; 32(2):479-494. PubMed ID: 33239394
[TBL] [Abstract][Full Text] [Related]
35. Prognostic Value of the Persistence of C1q-Binding Anti-HLA Antibodies in Acute Antibody-Mediated Rejection in Kidney Transplantation.
Bailly E; Anglicheau D; Blancho G; Gatault P; Vuiblet V; Chatelet V; Morelon E; Malvezzi P; Parissiadis A; Tourret J; Guidicelli G; Sayegh J; Mousson C; Grimbert P; Top I; Le Quintrec M; Purgus R; Westeel PF; Proust B; Chabot V; Lebranchu Y; Dehaut F; Büchler M
Transplantation; 2018 Apr; 102(4):688-698. PubMed ID: 29135832
[TBL] [Abstract][Full Text] [Related]
36. Antibody-mediated rejection due to anti-HLA-DQ antibody after pregnancy and delivery in a female kidney transplant recipient.
Sagasaki M; Nakada Y; Yamamoto I; Kawabe M; Yamakawa T; Katsumata H; Mafune A; Katsuma A; Kobayashi A; Koike K; Koike Y; Miki J; Yamada H; Kimura T; Tanno Y; Ohkido I; Tsuboi N; Yamamoto H; Yokoo T
Nephrology (Carlton); 2018 Jul; 23 Suppl 2():81-84. PubMed ID: 29968405
[TBL] [Abstract][Full Text] [Related]
37. Hyperacute rejections of two consecutive renal allografts and early loss of the third transplant caused by non-HLA antibodies specific for endothelial cells.
Sumitran-Karuppan S; Tyden G; Reinholt F; Berg U; Moller E
Transpl Immunol; 1997 Dec; 5(4):321-7. PubMed ID: 9504155
[TBL] [Abstract][Full Text] [Related]
38. The fate of renal allografts hinges on responses of the microvascular endothelium.
Mannam VK; Lewis RE; Cruse JM
Exp Mol Pathol; 2013 Apr; 94(2):398-411. PubMed ID: 22710034
[TBL] [Abstract][Full Text] [Related]
39. Significant association between chronic antibody-mediated rejection and donor-specific antibodies against HLA-DRB rather than DQB in renal transplantation.
Kobayashi T; Maruya E; Niwa M; Saji H; Kohara S; Katayama A; Takeda A; Watarai Y; Uchida K
Hum Immunol; 2011 Jan; 72(1):11-7. PubMed ID: 20974206
[TBL] [Abstract][Full Text] [Related]
40. Increasing relevance of donor-specific antibodies in antibody-mediated rejection.
Zito A; Schena A; Grandaliano G; Gesualdo L; Schena FP
J Nephrol; 2013; 26(2):237-42. PubMed ID: 23475460
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
